Clinical trials
16 active studies led by Janssen-Cilag Ltd., of 222 in all
Source: ClinicalTrials.gov, Studies with Janssen-Cilag Ltd. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 3Markets in public records
- 0Regions & countries
- 16Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Janssen-Cilag Ltd. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on Janssen-Cilag Ltd.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
Company facts
- Website
- janssen-cilag.de
- Home country
- Germany
- Type
- Medicines
Source: Wikidata, Company record Q1682988. Retrieved 13 Nov 2026.
See them on ClinicalTrials.gov (opens in a new tab)
Trials over time
Studies Janssen-Cilag Ltd. leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with Janssen-Cilag Ltd. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show Janssen-Cilag Ltd.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets Janssen-Cilag Ltd. is in.
From our blog
Stories on the topics Janssen-Cilag Ltd. works in.
Prebiotics: Feeding the Good Bacteria
More than 90% of US women and 97% of men do not eat enough fibre. Prebiotics are the fibres that feed helpful…
Read
Gut Health and Probiotics: What the Science Says
Gut health is one of the biggest wellness trends. Probiotics help in some cases, but not all products or…
Read
Molecular Point-of-Care Tests: Lab Accuracy, Clinic Speed
TB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade…
Read